Cargando…

Remimazolam: An Updated Review of a New Sedative and Anaesthetic

Remimazolam (CNS7056) is a novel benzodiazepine for intravenous sedation; it has an ultra-short duration of action and was recently approved for use in procedural sedation and general anaesthesia. It acts on γ-aminobutyric acid type A receptors and is rapidly converted into an inactive metabolite by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qinxue, Liu, Xing, Wen, Chengli, Li, Duo, Lei, Xianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675580/
https://www.ncbi.nlm.nih.gov/pubmed/36411859
http://dx.doi.org/10.2147/DDDT.S384155

Ejemplares similares